Skip to main content
Delfa

Lead sponsor

LeonaBio

5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.

5

Trials led

0

Ongoing

1,170

Total enrollment

23

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 2
2
Phase 2/3
2

Trials by status

Completed
3
Terminated
2

Trials led

TrialEligibility highlightPhaseStatusEnrollment
LIFT-ADmild-to-moderate AD / moderate AD dementiaPh 2/3Completed554
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseStudy partner/caregiver requiredPh 2/3Terminated423
Safety, Tolerability, and Pharmacokinetics Study of NDX-1017Alzheimer's diseasePh 1Completed88
ACT-ADmild-to-moderate AD / moderate AD dementiaPh 2Completed77
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)Parkinson's disease dementiaPh 2Terminated28